LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 227.80%9.84M | 259.53%879K | 300.55%3.66M | 111.92%336K | 298.21%4.97M | -247.98%-7.7M | -583.33%-551K | -133.44%-1.82M | 1.09%-2.82M | -200.76%-2.51M |
Net income from continuing operations | 32.55%-8.49M | 95.54%-536K | 142.65%438K | -69.73%970K | -241.03%-9.36M | -172.45%-12.58M | -387.23%-12.02M | -110.05%-1.03M | 63.05%3.2M | -375.23%-2.74M |
Operating gains losses | ---2.2M | --0 | --0 | ---2.22M | --20K | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -39.57%3.03M | -54.41%719K | -52.33%738K | -51.97%720K | 119.59%852K | 189.88%5.01M | 295.24%1.58M | 232.19%1.55M | 245.39%1.5M | -9.77%388K |
Deferred tax | 96.66%-84K | -107.74%-71K | 103.49%9K | 100.10%3K | 28.57%-25K | -524.49%-2.51M | 54.90%917K | ---258K | ---3.14M | ---35K |
Other non cash items | ---- | ---- | ---- | ---- | ---- | --196K | ---- | ---- | ---- | ---- |
Change In working capital | 180.62%5.57M | -170.56%-1.09M | 153.55%1.58M | 101.94%100K | 1,469.78%4.99M | -162.50%-6.91M | 130.72%1.55M | -142.13%-2.95M | 5.33%-5.15M | -142.42%-364K |
-Change in receivables | 138.11%9.24M | 372.28%7.04M | -337.87%-3.04M | 106.25%130K | 60.11%5.11M | 182.89%3.88M | 123.30%1.49M | -87.26%1.28M | 63.09%-2.08M | 219.05%3.19M |
-Change in inventory | 181.59%5.14M | 128.03%440K | 2,334.41%2.08M | 230.46%2.39M | 107.98%223K | -70.85%-6.29M | -181.22%-1.57M | 97.08%-93K | -574.63%-1.84M | -29.38%-2.8M |
-Change in payables and accrued expense | -192.65%-9.75M | -226.50%-4.04M | 178.88%1.22M | 2.48%-3.3M | -128.27%-3.63M | -2,724.41%-3.33M | 199.16%3.19M | -559.35%-1.55M | -4,297.40%-3.39M | -151.57%-1.59M |
-Change in other current assets | ---- | ---- | 336.82%1.04M | 24.44%1.38M | 61.21%1.78M | ---- | ---- | 13.73%-440K | 290.88%1.11M | 634.30%1.11M |
-Change in other working capital | 181.51%948K | -254.50%-326K | 112.89%276K | -148.08%-502K | 643.48%1.5M | -120.74%-1.16M | -84.29%211K | -784.35%-2.14M | -7.53%1.04M | -109.78%-276K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 227.80%9.84M | 259.53%879K | 300.55%3.66M | 111.92%336K | 298.21%4.97M | -247.98%-7.7M | -583.33%-551K | -133.44%-1.82M | 1.09%-2.82M | -200.76%-2.51M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 94.24%-2.18M | 144.26%432K | -777.37%-3.33M | 104.08%1.48M | -237.50%-756K | -301.51%-37.83M | -20.49%-976K | -101.93%-380K | -45,212.50%-36.25M | -397.78%-224K |
Net PPE purchase and sale | 24.69%-2.18M | 144.26%432K | -254.68%-3.33M | 296.81%1.48M | -237.50%-756K | -115.41%-2.89M | -20.49%-976K | -104.77%-940K | -840.00%-752K | -397.78%-224K |
Net business purchase and sale | --0 | --0 | --0 | ---- | ---- | ---34.94M | --0 | --560K | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 94.24%-2.18M | 144.26%432K | -777.37%-3.33M | 104.08%1.48M | -237.50%-756K | -301.51%-37.83M | -20.49%-976K | -101.93%-380K | -45,212.50%-36.25M | -397.78%-224K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -190.59%-10.63M | -2,797.97%-3.99M | 22.49%-255K | -149.22%-5.86M | -2,740.00%-528K | 241.99%11.74M | -74.83%148K | 92.91%-329K | 907.26%11.9M | 100.73%20K |
Net issuance payments of debt | -200.99%-10.61M | -618.80%-3.94M | 52.51%-255K | -150.48%-5.86M | -3,871.43%-556K | 315.58%10.5M | -2,509.52%-548K | 88.46%-537K | 11,587.13%11.6M | 85.57%-14K |
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | -93.12%85K | -91.81%57K | --0 | --0 | -17.65%28K | 71.53%1.24M | 14.29%696K | 1,500.00%208K | 924.14%297K | -50.72%34K |
Net other financing activities | ---111K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -190.59%-10.63M | -2,797.97%-3.99M | 22.49%-255K | -149.22%-5.86M | -2,740.00%-528K | 241.99%11.74M | -74.83%148K | 92.91%-329K | 907.26%11.9M | 100.73%20K |
Net cash flow | ||||||||||
Beginning cash position | -71.98%13.13M | -7.84%13.18M | -26.69%13M | -61.75%17.03M | -71.98%13.13M | 42.75%46.87M | -70.33%14.31M | -37.61%17.73M | 36.13%44.53M | 42.75%46.87M |
Current changes in cash | 91.21%-2.97M | -94.49%-2.68M | 102.65%67K | 85.13%-4.04M | 235.95%3.69M | -315.11%-33.79M | -1,176.85%-1.38M | -112.34%-2.53M | -516.94%-27.17M | -813.13%-2.71M |
Effect of exchange rate changes | 1,673.08%922K | 182.61%585K | 112.95%116K | -97.83%8K | -42.74%213K | 103.11%52K | 116.82%207K | -23.25%-896K | 232.43%369K | 112.57%372K |
End cash Position | -15.59%11.09M | -15.59%11.09M | -7.84%13.18M | -26.69%13M | -61.75%17.03M | -71.98%13.13M | -71.98%13.13M | -70.33%14.31M | -37.61%17.73M | 36.13%44.53M |
Free cash flow | 146.83%4.96M | 185.85%1.31M | 111.63%322K | 75.25%-884K | 254.28%4.22M | -360.48%-10.6M | -119.40%-1.53M | -152.73%-2.77M | -21.88%-3.57M | -211.78%-2.73M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |